Swiss medical device maker Ypsomed to sell diabetes business
Ypsomed sells diabetes business to TecMed
Keystone-SDA
Select your language
Generated with artificial intelligence.
Listening: Swiss medical device maker Ypsomed to sell diabetes business
Bern-based injection device manufacturer Ypsomed announced on Tuesday that it was selling its diabetes-related activities to another Swiss company TecMed. The transaction is worth CHF420 million ($517 million).
This content was published on
1 minute
Keystone-SDA
Français
fr
Ypsomed cède les activités liées au diabète à TecMed
Original
“Proceeds from the sale will finance the expansion of the injection systems business,” said a statement. The transaction is expected to be completed in the second half of the year, subject to regulatory approval of the ongoing demerger.
In November, the company announced the start of the process of selling its diabetes care business. Following a comprehensive marketing phase involving both strategic and financial buyers, TecMed “emerged as the ideal partner to take over Ypsomed’s diabetes care business”.
Translated from German by DeepL/jdp
How we work
We select the most relevant news for an international audience and use automatic translation tools such as DeepL to translate them into English. An editor then briefly reviews the translation for clarity and accuracy before publication. Providing you with automatically translated news gives us the time to write more in-depth articles. The news stories we select have been written and carefully fact-checked by an external editorial team from news agencies such as Bloomberg or Keystone.
Did you find this explanation helpful? Please fill out this short survey to help us understand your needs by clicking hereExternal link.
External Content
Popular Stories
More
Climate solutions
Switzerland turns train tracks into solar power plants
In Switzerland more people are being referred to electrical therapies or psychedelic-assisted psychotherapy. Are there similar approaches where you live?
Zurich council insists on Bührle art collection provenance research
This content was published on
The Zurich Cantonal Council has insisted that the Zurich Art Society and the Bührle Foundation clarify the provenance of all paintings.
Kosovo President to make first state visit to Switzerland
This content was published on
Kosovo President Vjosa Osmani Sadriu is coming to Switzerland on a state visit at the invitation of the federal government.
Basel authorities clarify threatening gestures against Israel at Eurovision
This content was published on
The Basel cantonal police are investigating the alleged threatening behaviour of an anti-Israel demonstrator at the Eurovision parade.
Swiss army tests weapons systems for long-range defence
This content was published on
The Swiss army is examining the acquisition of weapons systems and ammunition to defend the country's borders over longer distances.
Trump’s promise to lower drug prices rattles Swiss pharma stocks
This content was published on
US President Trump wants to make medicines cheaper in the US, which could mean huge losses for drugmakers, including those in Switzerland.
Trial opens in Switzerland for murder case of school caretaker
This content was published on
The trial of a man who allegedly killed a 41-year-old man with three shots in the Maggia Valley in May 2023 begins on Monday.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.